Such findings highlight the need for further investigation of Parkin’s role in excitatory neurotransmission, and in particular how disruption of glutamatergic signaling due to its loss-of-function may contribute to the pathophysiology of PD and other brain disorders. The gene discussed is PRKN; the disease is brain disorder.